-
The New York Times |
Malaria quickly kills toddlers. But rapid diagnostic tests, a new suppository drug and bicycle ambulances can buy enough time to get stricken children to hospitals.
Dec 10, 2018
-
Diagnostics World Contributed Commentary | Growing evidence suggests biological markers of Alzheimer’s disease may begin forming decades before an individual begins experiencing symptoms. Because of this, researchers are finding ways to detect the disease earlier and with more accuracy than standard diagnostic methods.
Dec 10, 2018
-
Diagnostics World Brief | Insight Genetics has launched Insight TNBCtype, a new test for categorizing triple negative breast cancer (TNBC) tumors into distinct molecular subtypes through its wholly owned CLIA- and CAP-accredited lab, Insight Molecular Labs. Insight TNBCtype is the first CLIA-validated assay for TNBC molecular subtyping, and the company believes it will enable prospective clinical trials with pharmaceutical, biotechnology, and academic medical institutions and advance targeted therapies for TNBC patients, addressing a significant unmet need in oncology today.
Dec 7, 2018
-
Diagnostics World | Quest Diagnostics, in partnership with Humana, MultiPlan, and UnitedHealth Group’s Optum and UnitedHealthcare, have launched a pilot program that applies blockchain technology to improve data quality and reduce administrative costs associated with changes to healthcare provider demographic data.
Dec 5, 2018
-
Diagnostics World News Brief | Biocartis announced it has entered into an agreement with AstraZeneca. The goal of the agreement will be to obtain faster lung cancer molecular diagnostic biomarker results in Europe.
Nov 30, 2018
-
Diagnostics World | November featured news, products, and partnerships from around the diagnostics community from numerous companies, universities, and organizations, including BioIVT, Illumina, Certara, and more.
Nov 28, 2018
-
Forbes | Alphabet's Verily and Novartis eye-care subsidiary Alcon are pulling the plug on the glucose monitoring "smart lens" device the two companies had been attempting to build since 2014, according to a post by Verily chief technical officer Brian Otis on the company's website Friday.
Nov 19, 2018
-
Diagnostic World News Today’s diagnostic methods for Alzheimer's disease, which evaluate cognition using traditional pen and paper tests, are less than ideal. The results can be combined with physical health, medical history, and information from family members or caregivers. If a patient does not perform well on a cognitive test, there are other potential causes of memory loss that still need to be ruled out. Thankfully there's been a recent push to advance Alzheimer's disease diagnosis.
Nov 15, 2018
-
MobiHealthNews |
The wearable will connect to the Health Mate app, which can give users insights about ther heart rate and sleep patterns.
Nov 14, 2018
-
Diagnostics World News | AliveCor has announced research suggesting the use of AliveCor’s AI technology as a potential alternative to surgically implanted heart monitors.
Nov 13, 2018